X-Ray CA-NHP Not yet graded
CA licensed ingredient
Market presence10 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-015499
Compound index — X
31 substances begin with X. 0 of them carry an Etalyn grade; the remainder are marked not yet graded, which is a statement about Etalyn’s coverage and not about the substance. This page shows 31 of them, X-Ray – Xylose.
US-DRUGListed as a marketed drug substance in the United StatesEU-MEDActive substance in a centrally authorised EU medicineEU-HERBSubject of an EU herbal monographUS-CSAScheduled under the US Controlled Substances ActCA-NHPLicensed supplement ingredient in CanadaEU-CLAIMAppears in the EU nutrition and health claims registerEU-NOVELAppears in the EU novel food catalogueETALYNEtalyn has graded a claim about this substance
Xanomeline US-DRUG Not yet graded
US: bulk ingredient
Class as recordedCholinergic Muscarinic Agonist [EPC]; Cholinergic Muscarinic Agonists [MoA]; Cholinergic Muscarinic Antagonist [EPC]; Cholinergic Muscarinic Antagonists [MoA]
Earliest US approval2024
Market presence12 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015500
Xanthan EU-CLAIM Not yet graded
EU claims 0 authorised / 2 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Helps to maintain normal bowel function. Promotes intestinal regularity. Ensures a healthy digestive system/ function.” | Non-authorised | Art.13(1) | EFSA opinion |
| “Helps you to feel full for longer. Helps to limit feeling of hunger and food craving. Helps to increase feelings of fullness and satiety. Curbs the appetite. Helps in weight control programs by reducing appetite and calorie intake. Contributes to control/ reduce appetite. Helps to reduce body weight.” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-015501
Xanthan Gum CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: bulk ingredient for human prescription compounding
Class as recordedAllergens [CS]; Ammonium Ion Binding Activity [MoA]; Anti-coagulant [EPC]; Calcium Chelating Activity [MoA]
Market presence6 US product listings · 3 Canadian licensed products
Etalyn identifierETA-C-015502
Xanthine US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Ammonium Ion Binding Activity [MoA]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015503
Xanthium sibiricum CA-NHP Not yet graded
CA licensed ingredient
Market presence147 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-015504
Xanthium Strumarium Pollen US-DRUG Not yet graded
US: bla
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Adrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]
Market presence60 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015505
Xanthium Strumarium Var. Canadense Pollen US-DRUG Not yet graded
US: bla
Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Allergens [Chemical/Ingredient]
Market presence11 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015506
xanthohumol EU-CLAIM Not yet graded
EU claims 0 authorised / 2 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “The antioxidative properties of Xanthohumol strengthen body cells in fighting oxidation induced aging” | Non-authorised | Art.13(1) | EFSA opinion |
| “Xanthohumol protects body cells from harmful free radicals which damage cells, protects them from oxidation induced cell stress and reinforces cell protection.” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-015507
Xanthohumol in XERME®, a xanthohumol-enriched roasted malt extract EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Helps to maintain the integrity of DNA and protects against oxidative damage in the cells of the body.” | Non-authorised | Art.13(5) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-015508
Xanthoparmelia scabrosa EU-NOVEL Not yet graded
Novel, not yet authorised
Parts in scopeWhole
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-015509
Xanthosoma sagittifolium EU-NOVEL Not yet graded
Not novel in food
Parts in scopeCorm
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-015510
Xanthosoma violaceum Schott EU-NOVEL Not yet graded
Not novel in food
Parts in scopeCorm
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-015511
Xanthoxylum fraxineum CA-NHP Not yet graded
CA licensed ingredient
Market presence26 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-015512
XAV-939 US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015513
Xenon XE-127 US-DRUG Not yet graded
Earliest US approval1982
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015514
Xenon XE-129 US-DRUG Not yet graded
US: nda
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015515
Xenon XE-129 Hyperpolarized US-DRUG Not yet graded
US: nda
Class as recordedHyperpolarized Contrast Agent [EPC]; Magnetic Resonance Contrast Activity [MoA]
Earliest US approval2022
Market presence4 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015516
Xenon XE-133 US-DRUG Not yet graded
US: drug for further processing
Class as recordedInhalation Diagnostic Agent [EPC]; Radiopharmaceutical Activity [MoA]
Earliest US approval1974
Market presence5 US product listings · 7 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015517
Xerophyllum Asphodeloides CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: drug for further processing
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]; Animal Fur [CS]
Market presence23 US product listings · 9 Canadian licensed products
Etalyn identifierETA-C-015518
Xerophyllum Asphodeloides Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Cell-mediated Immunity [PE]
Market presence5 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015519
ximelagatran EU-MED Not yet graded
EU medicine: Application withdrawn
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-015520
Xylazine Hydrochloride US-DRUG Not yet graded
US: bulk ingredient
Market presence4 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015521
Xylene (mixed Isomers) US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Standardized Chemical Allergen [EPC]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015522
Xylitol CA-NHPEU-CLAIMUS-DRUG Not yet graded
EU claims 0 authorised / 1 refusedCA licensed ingredientUS: unapproved drug other
Class as recordedAcidifying Activity [MoA]; Adrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]
Market presence13 US product listings · 4 Canadian licensed products
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Xylitol helps reduce plaque formation Xylitol helps neutralize plaque acids Xylitol helps protect teeth against the formation of plaque” | Non-authorised | Art.13(1) | EFSA opinion |
Etalyn identifierETA-C-015523
Xylitol-sweetened chewing gum EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Xylitol is good for the health of ears. Maintains good health of the ears.” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-015524
Xylo- Pentane-1,2,3,4,5-pentol CA-NHP Not yet graded
CA licensed ingredient
Market presence73 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-015525
Xylo-oligosaccharides EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Prebiotic; Stimulate a healthy intestinal flora; Stimulates the growth of bifidobacteria.” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-015526
Xylometazoline Hydrochloride US-DRUG Not yet graded
US: bulk ingredient
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-015527
Xylooligosaccharides CA-NHP Not yet graded
CA licensed ingredient
Market presence68 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-015528